GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kolon TissueGene Inc (XKRX:950160) » Definitions » Accounts Payable & Accrued Expense

Kolon TissueGene (XKRX:950160) Accounts Payable & Accrued Expense : ₩11,566 Mil (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Kolon TissueGene Accounts Payable & Accrued Expense?

Kolon TissueGene's quarterly accounts payable & accrued expense declined from Mar. 2024 (₩14,587 Mil) to Jun. 2024 (₩11,077 Mil) but then increased from Jun. 2024 (₩11,077 Mil) to Sep. 2024 (₩11,566 Mil).

Kolon TissueGene's annual accounts payable & accrued expense increased from Dec. 2021 (₩5,184 Mil) to Dec. 2022 (₩6,378 Mil) and increased from Dec. 2022 (₩6,378 Mil) to Dec. 2023 (₩9,469 Mil).

Kolon TissueGene Accounts Payable & Accrued Expense Historical Data

The historical data trend for Kolon TissueGene's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kolon TissueGene Accounts Payable & Accrued Expense Chart

Kolon TissueGene Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial 7,723.10 4,221.30 5,184.08 6,377.55 9,468.91

Kolon TissueGene Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12,176.75 9,468.91 14,587.41 11,076.60 11,565.83

Kolon TissueGene Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Kolon TissueGene Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kolon TissueGene Inc (XKRX:950160) » Definitions » Accounts Payable & Accrued Expense
Comparable Companies
XKRX:950210 XKRX:087010 XKRX:005250 XKRX:310210 XKRX:182400 XKRX:052020 XKRX:215600 XKRX:298380 XKRX:064550 XKRX:358570 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
9713 Key West Avenue, Suite 300, Rockville, MD, USA, 20850
Website
https://www.tissuegene.com
Kolon TissueGene Inc is a biopharmaceutical company that develops regenerative therapies for the treatment of various orthopedic disorders. It is developing four product candidates, TG-C, TG-B, TG-D and TG-N for regeneration of cartilage, bone, disc and nerve.

Kolon TissueGene Headlines

No Headlines